THE BLOODPAC BLOG

Impact

Featured
New Op-Ed in STAT News: Address liquid biopsy disparities today to ensure equity in outcomes tomorrow
New Op-Ed in STAT News: Address liquid biopsy disparities today to ensure equity in outcomes tomorrow
Read More →
BLOODPAC Quarterly Newsletter: Q1-Q2 2024
BLOODPAC Quarterly Newsletter: Q1-Q2 2024
Read More →
Rethinking risk and risk assessment for liquid biopsy-based single- & multi-cancer screening
Rethinking risk and risk assessment for liquid biopsy-based single- & multi-cancer screening

At the 2024 annual meeting of the American Association for Cancer Research (AACR), BLOODPAC’s Early Detection and Screening Working Group (ED&S WG) hosted a session focusing on cancer risk and risk assessment for liquid biopsy-based single- and multi-cancer screening.

Read More →
BLOODPAC and JCO Precision Oncology Conversations
BLOODPAC and JCO Precision Oncology Conversations

Lauren Leiman, Executive Director at BLOODPAC and Dr. Emma Alme, Public Policy Director at Guardant Health sat down with JCO Podcast host, Dr. Rafeh Naqash to discuss accessibility to liquid biopsy for cancer, potential barriers and proposed solutions.

Read More →
BLOODPAC Quarterly Newsletter: Q3 2023
BLOODPAC Quarterly Newsletter: Q3 2023
Read More →
Understanding Circulating Tumor Cell-Based Liquid Biopsy
Understanding Circulating Tumor Cell-Based Liquid Biopsy

In this article, we explore the identification, characterization, analysis, and clinical applications of circulating tumor cells in blood-based liquid biopsy for cancer management.

Read More →
Understanding Liquid Biopsy for Early Cancer Detection and Screening
Understanding Liquid Biopsy for Early Cancer Detection and Screening

Advances in cancer detection have historically lagged behind the development of new cancer treatments. Liquid biopsy is poised to change this. The development of blood-based cancer detection assays in the past several years has led to numerous high-profile studies and hundreds of thousands of individuals enrolled in clinical trials.

Read More →
BLOODPAC Quarterly Newsletter: Q2 2023
BLOODPAC Quarterly Newsletter: Q2 2023
Read More →
Understanding BLOODPAC’s Analytical Validation Protocols for Late-Stage Solid Tumor ctDNA Assays
Understanding BLOODPAC’s Analytical Validation Protocols for Late-Stage Solid Tumor ctDNA Assays
Read More →
Understanding Liquid Biopsy for Brain Cancer
Understanding Liquid Biopsy for Brain Cancer

Any cancer diagnosis is devastating, but the discovery of a brain tumor comes with a unique set of challenges for both patient and doctor. In this article, we discuss the potential role of liquid biopsy for management of brain cancer, current research in this space, and remaining questions in the field.

Read More →
BLOODPAC Quarterly Newsletter: Q1 2023
BLOODPAC Quarterly Newsletter: Q1 2023
Read More →
Understanding Molecular Residual Disease (MRD) in Clinical Trials
Understanding Molecular Residual Disease (MRD) in Clinical Trials
Read More →
Thought Leaders in Liquid Biopsy: Dr. Howard Scher (Memorial Sloan Kettering Cancer Center)
Thought Leaders in Liquid Biopsy: Dr. Howard Scher (Memorial Sloan Kettering Cancer Center)
Read More →
Understanding Molecular Residual Disease (MRD) in Solid Tumors
Understanding Molecular Residual Disease (MRD) in Solid Tumors
Read More →
Thought Leaders in Liquid Biopsy: A Conversation with Dr. Anne-Marie Martin (Global Head of Experimental Medicine, GSK)
Thought Leaders in Liquid Biopsy: A Conversation with Dr. Anne-Marie Martin (Global Head of Experimental Medicine, GSK)
Read More →
Understanding Tumor Mutational Burden (TMB)
Understanding Tumor Mutational Burden (TMB)
Read More →
Thought Leaders in Liquid Biopsy: A Conversation with Dr. Phil Febbo (CMO, Illumina)
Thought Leaders in Liquid Biopsy: A Conversation with Dr. Phil Febbo (CMO, Illumina)
Read More →
Contrived Materials in Liquid Biopsy Assay Development
Contrived Materials in Liquid Biopsy Assay Development
Read More →
New Paper on Contrived Materials in Liquid Biopsy Validation from BLOODPAC
New Paper on Contrived Materials in Liquid Biopsy Validation from BLOODPAC
Read More →
BLOODPAC Publishes a Roadmap for Early Cancer Detection and Screening using Liquid Biopsy
BLOODPAC Publishes a Roadmap for Early Cancer Detection and Screening using Liquid Biopsy
Read More →
BLOODPAC Hosts Brain Cancer Virtual Webinar
BLOODPAC Hosts Brain Cancer Virtual Webinar
Read More →
BLOODPAC and Epic Sciences: Building Collaboration
BLOODPAC and Epic Sciences: Building Collaboration
Read More →
BLOODPAC Working Group Publishes on COVID-19 Testing Requirements
BLOODPAC Working Group Publishes on COVID-19 Testing Requirements
Read More →
College of American Pathologists extends support of BLOODPAC’s MTDEs
College of American Pathologists extends support of BLOODPAC’s MTDEs
Read More →
BloodPAC Moves Forward With Liquid Biopsy Data Commons</a>
BloodPAC Moves Forward With Liquid Biopsy Data Commons
Read More →
Breast Cancer Research Foundation &amp; Prostate Cancer Foundation Commit to Supporting BLOODPAC
Breast Cancer Research Foundation & Prostate Cancer Foundation Commit to Supporting BLOODPAC
Read More →
Blood Profiling Atlas in Cancer: Identifying the Mission
Blood Profiling Atlas in Cancer: Identifying the Mission
Read More →
Public &amp; Private Sector Actions to Advance Cancer Moonshot Goals</a>
Public & Private Sector Actions to Advance Cancer Moonshot Goals
Read More →

Never miss an update

Subscribe to our blog for the latest news, updates and more.